Understanding Patient and Provider Perspective on Impact of Professional Continuous Glucose Monitors on Diabetes Control in a Complex Care Population

摘要

Since continuous glucose monitors (CGMs) first became commercially available in 2000, numerous studies have shown that their use improves the management of diabetes for both pediatric and adult patients and both type 1 and type 2 diabetes.1-5 However, there remain little data on their efficacy in certain subpopulations such as patients with significant medical comorbidities, mental health conditions, or substantial social barriers, who were largely excluded from the studies of CGM’s efficacy.6